These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 23111168)

  • 1. What you always needed to know about electroporation based DNA vaccines.
    Gothelf A; Gehl J
    Hum Vaccin Immunother; 2012 Nov; 8(11):1694-702. PubMed ID: 23111168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimisation of intradermal DNA electrotransfer for immunisation.
    Vandermeulen G; Staes E; Vanderhaeghen ML; Bureau MF; Scherman D; Préat V
    J Control Release; 2007 Dec; 124(1-2):81-7. PubMed ID: 17854939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA vaccination in skin enhanced by electroporation.
    Broderick KE; Khan AS; Sardesai NY
    Methods Mol Biol; 2014; 1143():123-30. PubMed ID: 24715285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity and Biodistribution of Anthrax DNA Vaccine Delivered by Intradermal Electroporation.
    Kim NY; Son WR; Choi JY; Yu CH; Hur GH; Jeong ST; Shin YK; Hong SY; Shin S
    Curr Drug Deliv; 2020; 17(5):414-421. PubMed ID: 32286944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parameters for DNA vaccination using adaptive constant-current electroporation in mouse and pig models.
    Draghia-Akli R; Khan AS; Brown PA; Pope MA; Wu L; Hirao L; Weiner DB
    Vaccine; 2008 Sep; 26(40):5230-7. PubMed ID: 18450333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electroporation-enhanced delivery of nucleic acid vaccines.
    Broderick KE; Humeau LM
    Expert Rev Vaccines; 2015 Feb; 14(2):195-204. PubMed ID: 25487734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene electrotransfer to skin; review of existing literature and clinical perspectives.
    Gothelf A; Gehl J
    Curr Gene Ther; 2010 Aug; 10(4):287-99. PubMed ID: 20557284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Basic principles and clinical advancements of muscle electrotransfer.
    Hojman P
    Curr Gene Ther; 2010 Apr; 10(2):128-38. PubMed ID: 20222860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccine submission with muscle electroporation.
    Yuan TF
    Vaccine; 2008 Mar; 26(15):1805-6. PubMed ID: 18313811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimization of skin electroporation in mice to increase tolerability of DNA vaccine delivery to patients.
    Roos AK; Eriksson F; Walters DC; Pisa P; King AD
    Mol Ther; 2009 Sep; 17(9):1637-42. PubMed ID: 19532140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical potential of electroporation for gene therapy and DNA vaccine delivery.
    Lambricht L; Lopes A; Kos S; Sersa G; Préat V; Vandermeulen G
    Expert Opin Drug Deliv; 2016; 13(2):295-310. PubMed ID: 26578324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delivery of DNA into skin via electroporation.
    Medi BM; Singh J
    Methods Mol Biol; 2008; 423():225-32. PubMed ID: 18370202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Duration and level of transgene expression after gene electrotransfer to skin in mice.
    Gothelf A; Eriksen J; Hojman P; Gehl J
    Gene Ther; 2010 Jul; 17(7):839-45. PubMed ID: 20376097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electroporation-based DNA delivery technology: methods for gene electrotransfer to skin.
    Gothelf A; Gehl J
    Methods Mol Biol; 2014; 1143():115-22. PubMed ID: 24715284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biodistribution, persistence and lack of integration of a multigene HIV vaccine delivered by needle-free intradermal injection and electroporation.
    Bråve A; Gudmundsdotter L; Sandström E; Haller BK; Hallengärd D; Maltais AK; King AD; Stout RR; Blomberg P; Höglund U; Hejdeman B; Biberfeld G; Wahren B
    Vaccine; 2010 Nov; 28(51):8203-9. PubMed ID: 20951666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electroporation for therapeutic DNA vaccination in patients.
    Sällberg M; Frelin L; Ahlén G; Sällberg-Chen M
    Med Microbiol Immunol; 2015 Feb; 204(1):131-5. PubMed ID: 25535102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The site of administration influences both the type and the magnitude of the immune response induced by DNA vaccine electroporation.
    Vandermeulen G; Vanvarenberg K; De Beuckelaer A; De Koker S; Lambricht L; Uyttenhove C; Reschner A; Vanderplasschen A; Grooten J; Préat V
    Vaccine; 2015 Jun; 33(28):3179-85. PubMed ID: 25980430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of electroporation in DNA vaccination protocols.
    Chiarella P; Fazio VM; Signori E
    Curr Gene Ther; 2010 Aug; 10(4):281-6. PubMed ID: 20504275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced Delivery of DNA or RNA Vaccines by Electroporation.
    Broderick KE; Humeau LM
    Methods Mol Biol; 2017; 1499():193-200. PubMed ID: 27987151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skin targeted DNA vaccine delivery using electroporation in rabbits II. Safety.
    Medi BM; Singh J
    Int J Pharm; 2006 Feb; 308(1-2):61-8. PubMed ID: 16356671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.